| | Wall Street ends higher after upbeat data | NEW YORK (Reuters) - U.S. stocks rose on Thursday, after a batch of economic data pointed to an improving economy and investors reassessed comments from Fed Chair Janet Yellen that fueled speculation of an earlier-than-expected rate hike by the central bank. | | | | | U.S. jobs, factory data show improvement; housing lags | WASHINGTON (Reuters) - The number of Americans filing for jobless benefits hovered near three-month lows last week and factory activity in the Mid-Atlantic region rebounded this month, suggesting the economy is regaining strength after being hobbled by severe weather. | | | | | | All big U.S. banks but one pass Fed's health test | WASHINGTON (Reuters) - U.S. big banks have enough capital buffers to withstand a drastic economic downturn, the Federal Reserve said on Thursday, announcing that 29 out of 30 major banks met the minimum hurdle in its annual health check. | | | | | | With cars, drivers, Google revs up home delivery | SAN FRANCISCO (Reuters) - When Google started testing a free same-day shopping delivery service in San Francisco last year, industry observers were surprised by the company's foray into a notoriously tricky and decidedly low-margin real-world business. | | | | | | Nike profit rises; future orders soar 14 percent | (Reuters) - Nike Inc on Thursday reported a higher quarterly profit from continuing operations as high margin products made up a bigger proportion of sales, and said global orders for merchandise for delivery by July rose 14 percent. | | | | | | Europe strikes deal to complete banking union | BRUSSELS (Reuters) - Europe took the final step to complete a banking union on Thursday with an agency to shut failing euro zone banks, but there will be no joint government back-up to pay the costs of closures. | | | | | | J&J gets $1.2 billion Arkansas Risperdal judgment tossed out | (Reuters) - Johnson & Johnson on Thursday won a reversal by the Arkansas Supreme Court of a $1.2 billion judgment imposed after a jury concluded that the drugmaker improperly marketed its anti-psychotic drug Risperdal and concealed its risks. | | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment